LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)
LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)
Enrolling by invitation · NCT04762992 · Registry updated 2025-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Premature Birth, Urogenital Diseases, fetal growth restriction, hereditary endocrine growth disease, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder | Enrolling by invitation | Phase 3 | 2025-08-13 | NCT04762992 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centro Hospitalar de Lisboa Central | 8 |
| NOVA Medical School | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centro de Diagnóstico Pré-Natal, Maternidade Dr. Alfredo da Costa, Centro Hospitalar Universitário de Lisboa Central | Lisbon | Portugal | 1 |